Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Caesars Entertainment Corp (CZR)

Page 1 of 2

The worries about the economic slowdown in China and the ongoing uncertainty about the path of interest-rate increases triggered several waves of equity sell-offs during the third quarter. Of course, most hedge funds and other asset managers had to stomach substantial losses during the bloody three-month period, which might have caused some to consider fleeing the U.S. equity markets. Interestingly, smaller-cap stocks registered higher losses than large-capitalization stocks during the September quarter, suggesting that institutional investors heavily discarded seemingly riskier equities amid high uncertainty and turmoil. In fact, the Russell 2000 Index lost 11.9% in the third quarter, while the Standard and Poor’s 500 benchmark declined a mere 6.4%. This article will lay out and discuss the hedge fund and institutional investor sentiment towards Caesars Entertainment Corp (NASDAQ:CZR).

Is Caesars Entertainment Corp (NASDAQ:CZR) an attractive investment today? Investors who are in the know are taking a bullish view. The number of bullish hedge fund positions went up by 1 in recent months. CZR was in 23 hedge funds’ portfolios at the end of the third quarter of 2015. There were 22 hedge funds in our database with CZR positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as InvenSense Inc (NYSE:INVN), Nuveen Performance Plus Municipal Fund (NYSE:NPP), and Berkshire Hills Bancorp, Inc. (NYSE:BHLB) to gather more data points.

Follow Caesars Entertainment Corp (NASDAQ:CZR)
Trade (NASDAQ:CZR) Now!

According to most stock holders, hedge funds are seen as worthless, outdated investment vehicles of yesteryear. While there are more than 8000 funds in operation at the moment, Our experts choose to focus on the elite of this group, about 700 funds. Most estimates calculate that this group of people preside over most of the hedge fund industry’s total capital, and by observing their best equity investments, Insider Monkey has found various investment strategies that have historically defeated the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

With all of this in mind, let’s take a look at the latest action encompassing Caesars Entertainment Corp (NASDAQ:CZR).

How have hedgies been trading Caesars Entertainment Corp (NASDAQ:CZR)?

At Q3’s end, a total of 23 of the hedge funds tracked by Insider Monkey were long this stock, a change of 5% from the second quarter. With hedgies’ capital changing hands, there exists an “upper tier” of notable hedge fund managers who were boosting their stakes significantly (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, John Paulson’s Paulson & Co has the largest position in Caesars Entertainment Corp (NASDAQ:CZR), worth close to $85.2 million, accounting for 0.4% of its total 13F portfolio. On Paulson & Co’s heels is Kenneth Mario Garschina of Mason Capital Management, with a $42.4 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Remaining hedge funds and institutional investors with similar optimism encompass Joshua Friedman and Mitchell Julis’s Canyon Capital Advisors, George Soros’ Soros Fund Management and Matthew Knauer and Mina Faltas’s Nokota Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!